Status:
COMPLETED
Estivation of Malaria Vector Mosquitoes in the Sahelian Region of Mali
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Malaria
Eligibility:
MALE
18-65 years
Brief Summary
Background: * P. falciparum, one of the most virulent forms of malaria, causes more than 300 million episodes of malaria and 1 million deaths each year. The spread of drug-resistant parasites, insect...
Detailed Description
Malaria causes over one million deaths annually. A promising control strategy relies on targeting mosquito populations when they are vulnerable, such as during the dry season. Prolonged dry season dur...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Age 18-65 years
- Only healthy male adults who are free of acute and chronic illnesses will participate.
- Permanent residency in Thierola
- Ability to collect mosquitoes after being trained
Exclusion
Key Trial Info
Start Date :
March 3 2009
Trial Type :
OBSERVATIONAL
End Date :
March 10 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00863408
Start Date
March 3 2009
End Date
March 10 2010
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892